Rancan Impex Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 9.22 Cr
- Company Age 35 Year, 6 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 2.00 Cr
- Revenue Growth -12.53%
- Profit Growth -93.64%
- Ebitda -99.41%
- Net Worth 1.79%
- Total Assets -49.17%
About Rancan Impex
Rancan Impex Private Limited (RIPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 July 1989 and has a history of 35 years and six months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.22 Cr.
The company currently has active open charges totaling ₹2.00 Cr.
Naveen Chaudhri and Amita Chaudhri serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74899DL1989PTC036968
-
Company No.
036968
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Jul 1989
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Rancan Impex?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naveen Chaudhri
|
Managing Director | 01-Sep-1993 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Amita Chaudhri
|
Director | 17-Jul-1989 | Current |
Financial Performance of Rancan Impex.
Rancan Impex Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 12.53% decrease. The company also saw a substantial fall in profitability, with a 93.64% decrease in profit. The company's net worth moved up by a moderate rise of 1.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rancan Impex?
In 2017, Rancan Impex had a promoter holding of 85.27% and a public holding of 14.73%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Nmc Biopharm LimitedNaveen Chaudhri and Amita Chaudhri are mutual person
-
Nmc-Sky Diagnostics Private Limited
Naveen Chaudhri and Amita Chaudhri are mutual person
Charges (Loans)
₹2.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Delhi Safe Depostis Company Limited : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Sep 2010 | Delhi Safe Depostis Company Limited | ₹2.00 Cr | Open |
How Many Employees Work at Rancan Impex?
Unlock and access historical data on people associated with Rancan Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rancan Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rancan Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
